Cleaning Validation : Practical Compliance Approaches for Pharmaceutical Manufacturing

個数:

Cleaning Validation : Practical Compliance Approaches for Pharmaceutical Manufacturing

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 204 p.
  • 言語 ENG
  • 商品コード 9781032431734
  • DDC分類 615.19

Full Description

Pharmaceutical manufacturers and upper management are encouraged to meet the

challenges of the science-based and risk-based approaches to cleaning validation.

Using some of the principles and practices in this volume will help in designing a

more effective and efficient cleaning validation program.

Features

• Timely coverage of cleaning validation for the pharmaceutical industry,

a dynamic area in terms of health-based limits.

• The author encourages pharmaceutical manufacturers, and particularly

upper management, to meet the challenges of the science-based and riskbased

approaches to cleaning validation.

• Draws on the author's vast experience in the field of cleaning validation

and hazardous materials.

• Discusses EMA vs. ISPE on Cleaning Limits and revised Risk-MaPP for

highly hazardous products in shared facilities.

• A diverse list of topics from protocol limits for yeasts and molds to

cleaning validation for homeopathic drug products.

Contents

Terminology




Use of the Term "Product"



Use of the Terms Grouping and Matrixing



Deviations and Nonconformances



Clarifying Terms: Blanks vs. Controls



Meaning of "Dedicated"?



Words (Again??)

Health-based Limits




What's at Stake with HBELs



A Look at the Revised Risk-MaPP



EMA's Q&A Clarification: Part 1



EMA's Q&A Clarification: Part 2



The EMA Q&A "Clarification" on Limits



The EMA Q&A on Routine Analytical Testing



Other Issues in EMA's Q&A



Highly Hazardous Products in Shared Facilities

Limits - General




EMA vs. ISPE on Cleaning Limits?



Does a High "Margin of Safety" Protect Patients?



What If the Next Product is the Same Product?



Limits for "Product A to Product A"



Surfaces Areas in Carryover Calculations



Carryover Calculation Errors to Avoid



Protocol Limits for Yeasts/Molds?



Cleaning Validation for Homeopathic Drug Products



A Possible Approach for Biotech Limits



Establishing Clearance for Degraded Protein Actives

Visually Clean




Avoiding "Visually Dirty" Observations



What's a Visual Limit?



Visual Residue Limits - Part 1



Visual Residue Limits - Part 2
Analytical and Sampling Methods




Two More Nails in the Coffin?



More Swab Sampling Issues



Timing for Swab Sampling in a Protocol?



Pass/Fail Analytical Test Methods

Product Grouping




Issues in Product Grouping



Toxicity as a Worst-Case Grouping Factor



Another "Worst Case" Product Grouping Idea

Protocols and Procedures




Issues in Rinsing - Part 1



Issues in Rinsing - Part 2



Routine Monitoring for Highly Hazardous Products



"Concurrent Release" for Cleaning Validation



Dirty and Clean Hold Time Protocols

API Manufacture




A Critique of the APIC Guideline



Another Issue for API Synthesis



Contaminants in API Manufacture

Miscellaneous




Significant Figures: Back to Basics



The Value of a Protocol Worksheet for Manual Cleaning



Dealing with Used and New Equipment



Solving Cleaning Validation Problems by Analogy



Causing Cleaning Validation Problems by Analogy

Appendix A: Acronyms Used in this Volume

Appendix B: Shorthand Notations for Expressing Limits

Index

最近チェックした商品